What DIVASA-FARMAVIC does

DIVASA-FARMAVIC, S.A. (trading as DFV Group) is a Spanish private veterinary pharmaceutical company headquartered in Gurb-Vic (Vic), Spain. The group organizes its activities into three functions: production via several plants using advanced manufacturing technology; development through multiple R&D teams that adapt formulations to changing regulatory requirements; and marketing through a combination of wholly-owned subsidiaries and external distributor networks. Core revenue streams include veterinary pharmaceuticals (anti-infectives, anti-parasitics, anti-inflammatories, hormonal products, dermatological products, nutritional supplements), the DFV Test line of immunochromatographic rapid diagnostic tests for in-clinic disease detection, veterinary instruments, and contract manufacturing services for third-party veterinary pharmaceutical companies.

The company's technical differentiation rests on three proprietary platforms. First, DFV® Protect technology uses specifically selected microalgae extracts with anti-adherent properties to produce dermatological products that prevent microorganism adhesion to animal skin. Second, several patented oral formulations deliver water-soluble solutions with superior stability and efficacy across different water types. Third, the DFV® Test line provides rapid in-clinic diagnostics for Giardia, Parvo/Corona, Dirofilaria, FeLV/FIV, Leishmania, Ehrlichia, and Anaplasma, developed through university-supported biotechnology research. Sub-brands include DFV Derm (dermatology), DFV Test (diagnostics), Taberdog (anti-parasitic collars and shampoos), and Tabernil (ornamental bird products).

DFV operates a multi-channel go-to-market model: direct sales in Spain, wholly-owned subsidiaries in Ecuador, Portugal, Venezuela, and Mexico managing local distribution with dedicated sales teams, and authorized distributor networks reaching more than 60 countries across Europe, Africa, Asia, the Middle East, and the Americas. The company is sales-led, supported by trade show participation (CPhI, EuroTier, VIV Asia, ANEMBE, GEDA), a WhatsApp-based technical support service for veterinary professionals, and a dedicated contract manufacturing brand marketed through CPhI. Customer segments are veterinary professionals, companion animal owners, and livestock operations. The company is EU GMP certified and holds dedicated pharmacovigilance and data protection functions, indicating regulatory maturity for multi-jurisdiction veterinary pharmaceutical distribution.

Name

DIVASA-FARMAVIC

Legal name

DIVASA-FARMAVIC, S.A.

Website

https://divasa-farmavic.com

Company type

Private

Founded year

1970

Operating status

Operating

Headcount range

51–100 employees

Short description

DIVASA-FARMAVIC (DFV Group) is a Spanish private veterinary pharmaceutical manufacturer producing pharmaceuticals, immunochromatographic rapid diagnostic tests, and dermatological products for veterinary professionals, companion animal owners, and livestock operations across 60+ countries via subsidiaries and distributors.

Ownership category

akta.pro rank

Product category

Veterinary Pharmaceuticals

NAICS

Veterinary Services (54194)

SIC

Pharmaceutical Preparations (2834), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Livestock & Production Animal Therapeutics (Rx) (HLAMAEAB)

akta.pro secondary industries

Diagnostics & Laboratory Services (Sampling, Necropsy, Disease Investigation) (AFACADAF), Veterinary Pharmacy, Vaccine & Biologics Services (AFAEANAK)

Keywords

• Veterinary pharmaceuticals
• Animal health products
• Veterinary diagnostic tests
• Veterinary dermatology products
• Contract manufacturing

Headquarters

HQ city

Gurb

HQ country

Spain

HQ region

Europe

Offices5 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. Veterinary Pharmaceuticals: Production and sale of pharmaceutical products for animals including anti-infectives, anti-parasitics, anti-inflammatories, hormonal products, dermatological products, nutritional supplements, and circulatory/metabolic regulators for companion animals and production livestock.
2. Rapid Diagnostic Tests: Sale of immunochromatographic diagnostic tests (DFV® TEST line) for veterinary clinics to detect diseases in pets and production animals. Tests are sold in various packaging formats (individual units, clinical packs).
3. Veterinary Instruments: Development and sale of veterinary instruments and equipment adapted for clinical field use, featuring reliable, precise, long-lasting, and easy-to-use products.
4. Contract Manufacturing: Third-party manufacturing services for the veterinary pharmaceutical sector through dedicated website dfv-contractmanufacturing.com. The company positions itself as a reference for contract manufacturing in the veterinary sector, participating in CPhI to expand this business.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels3 records

Core offering

DIVASA-FARMAVIC (DFV® Group) manufactures and sells veterinary pharmaceutical products for companion animals and production livestock, including anti-infectives, anti-parasitics, anti-inflammatories, hormonal products, dermatological products, nutritional supplements, and metabolic regulators. The group also produces immunochromatographic rapid diagnostic tests (DFV® Test line), veterinary instruments, and contract manufacturing services for the veterinary pharmaceutical sector.

Product overview

DIVASA-FARMAVIC (DFV Group) is an animal health and welfare company operating across four main segments: companion animals (pets), production animals (livestock), veterinary diagnostics, and contract manufacturing. The product portfolio includes the DFV Test line of immunochromatographic rapid diagnostic tests for pets, the DFV Derm dermatological line featuring proprietary microalgae extract technology (DFV Protect), the Taberdog and Tabernil external antiparasitic product lines, equine products (Hyaludol, Equitech Butazona), and Aerofar wound treatment. The company offers contract manufacturing services for the veterinary pharmaceutical sector.

Differentiator

Problem solved

Functional benefit

Brands

• DFV DERM: Dermatological product line for animals with DFV Protect technology
• DFV Test
• Taberdog
• Tabernil

Products and services

• DFV Test Line Immunochromatographic rapid in-clinic diagnostic tests for detection of antigens and antibodies in pets, including Giardia, Dirofilaria (Heartworm), FeLV, FIV, Leishmania, Ehrlichia, Anaplasma, and Parvo/Corona. Designed for veterinary clinics to obtain timely disease detection results.
• DFV Derm Line Dermatological products for pets featuring DFV® Protect technology using microalgae extracts with anti-adherent properties. Includes shampoos (Sensitive A1, Seborrea S1, PrO P1), otic lotion (O1), and display units for veterinary clinics.
• Taberdog Line External antiparasitic products for dogs including medicated collars (Dimpilato and Permetrina) and shampoo (Tetrametrina + BP) for protection against fleas, ticks, flies, and mosquitoes.
• Tabernil Line Products for ornamental birds including vitamin supplements (AD3E, complejo B), breeding aids (Cría), doxycycline treatment, spray insecticide (Tetrametrina + Piperonyl butoxide), and molting support (muda).
• Hyaludol Hyaluronic acid product with superior viscoelasticity for reactivation of joint functions in competition horses. Presented as individual pack containing 1 syringe of 3ml.
• Equitech Butazona Oral granular phenylbutazone with anti-inflammatory and analgesic effect for horses. Commercial presentation in boxes containing 20 sachets of 5g.
• Aerofar Cutaneous aerosol suspension containing chlortetracycline hydrochloride for treatment of superficial wounds in animals. Indicated for surgical wounds, superficial wounds, and podal infections. 335ml container (250g product).
• Contract Manufacturing Services Contract manufacturing services for the veterinary pharmaceutical sector. The company participates in CPhI Worldwide as a reference for contract manufacturing in the veterinary sector, leveraging its EU GMP-certified manufacturing plants.

Named customers1 record

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Three partnerships are on record, tiered core and minor.

• MeijicoreStrategic or Co-development Partner · 1 September 2024Meiji, along with Emdoka, visited DFV facilities in September 2024 for working sessions to strengthen existing collaboration between the three companies.
• EmdokacoreStrategic or Co-development Partner · 1 September 2024Emdoka, along with Meiji, visited DFV facilities in September 2024 for working sessions to strengthen existing collaboration between the three companies.
• Tac OsonaminorOthersSocial economy company providing workplace insertion for people with disabilities. Partnered with DFV for preparing product displays with new color references for TABERDOG® COLLAR PERMETRINA. DFV contributes to job insertion of people with disabilities through this collaboration.

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Direct peers

• Virbac: Independent global veterinary pharmaceutical company headquartered in France with a similar mid-sized, multi-species product portfolio spanning companion and production animals. Highly comparable segment scope and commercial model.
• Vetoquinol: French veterinary pharmaceutical group with comparable companion/livestock pharma and diagnostics portfolio. Both are privately anchored, mid-tier independent players competing against the multinational majors.
• Ceva Santé Animale: Independent French veterinary pharma company with strong livestock and emerging market presence. Directly comparable mix of pharmaceuticals, vaccines, and diagnostic devices targeting similar customers.
• Hipra: Spanish veterinary pharmaceutical and biological company headquartered in Catalonia. National direct competitor with overlapping product categories (vaccines, pharmaceuticals, diagnostics) and similar mid-sized private profile.
• Dechra Pharmaceuticals: UK-based veterinary pharmaceutical company specializing in companion and production animal therapeutics. Comparable in portfolio breadth across species and therapeutic categories.
• Norbrook Laboratories: Privately held Northern Irish veterinary pharmaceutical manufacturer with strong anti-infective and anti-parasitic portfolio. Comparable mid-size independent positioning with manufacturing focus.
• Phibro Animal Health: Diversified animal health and nutrition company with strong livestock pharmaceutical and nutritional supplement portfolio. Directly comparable in production animal pharma and nutritional supplement segments.

Broad incumbents

• Zoetis: Global animal health leader with extensive veterinary pharmaceutical, vaccine, and diagnostic portfolio across all species. Represents the dominant competitive incumbent whose scale and R&D budget frame DFV's competitive constraints.
• Elanco Animal Health: Major multinational animal health company with broad pharmaceutical and diagnostic portfolio. Operates within the same veterinary channel but at significantly larger scale and R&D intensity.
• Boehringer Ingelheim Animal Health: Animal health division of Boehringer Ingelheim offering vaccines, pharmaceuticals, and diagnostics. Overlaps with DFV in companion and livestock therapeutics and competes in the same veterinary channel.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/divasa-farmavic

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DIVASA-FARMAVIC